Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Finranks

Компания

  • О нас

Контакты

  • [email protected]

Мы в соцсетях

  • Instagram
  • Telegram
  • LinkedIn

Все права защищены.

Условия использования
  • Главная
  • Рынки
  • Скринер
  • Новости
  • О нас
  1. Home
  2. LGN

(LGN)

0.00

0.00 (0.00%)

  • Обзор
  • Новости
  • График
  • Финансы
  • Дивиденды
  • Прогноз
  • Владельцы
  • Профиль
Legence Corp.'s Surge Justifies A Respectful Downgrade
27.03.2026

Legence Corp.'s Surge Justifies A Respectful Downgrade

Legence Corp. delivered strong revenue growth and raised 2026 guidance, but profitability lagged expectations, tempering investor enthusiasm. LGN's Installation & Maintenance segment, fueled by surging data center demand, drove Q4 revenue up 34.5% year-over-year to $737.6 million. Major acquisitions, notably The Bowers Group, expanded backlog to $3.67 billion and underpin management's outlook for $3.7–$3.9 billion 2026 revenue.

Legence Reports Fourth Quarter and Year End 2025 Financial Results
27.03.2026

Legence Reports Fourth Quarter and Year End 2025 Financial Results

Record Quarterly Revenues of $737.6 Million, a 34.6% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 53% from Prior Year1 Record Total Backlog and Awards of $3.7 Billion, 49% Increase from a Year Ago, with Robust Q4 Book-to-Bill of 1.9x Tuck-In Acquisition of Seattle Area-Based Engineering Firm Establish First Quarter 2026 Guidance for Revenue of $925 Million - $950 Million and Non-GAAP Adjusted EBITDA of $90 Million - $100 Million Raise Full Year 2026 Guidance for Revenue to $3.7 Billion - $3.9 Billion and Non-GAAP Adjusted EBITDA of $400 Million - $430 Million SAN JOSE, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today reported financial results for the fourth quarter and year ended December 31, 2025.

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights
18.03.2026

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

The Fund rebounded and outperformed the Russell 2000 ® Growth Index in the fourth quarter. Boot Barn's revenues and earnings handily exceeded estimates, with greater transaction volumes and new store openings. Abivax reported strong clinical trial results for its obefazimod treatment to address ulcerative colitis in a longer lasting manner.

Engineering Services Stock Jumps 80% Since September IPO as $24 Million Investor Bet Emerges
12.03.2026

Engineering Services Stock Jumps 80% Since September IPO as $24 Million Investor Bet Emerges

Engle Capital bought 559,000 shares of Legence in the fourth quarter. The quarter-end position value increased by $24.06 million as a result.

Legence Sets Fourth Quarter and Full-Year 2025 Earnings Release Date and Webcast Schedule
20.02.2026

Legence Sets Fourth Quarter and Full-Year 2025 Earnings Release Date and Webcast Schedule

SAN JOSE, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that it will release results for the fourth quarter and full-year ended December 31, 2025 on Friday, March 27, 2026, prior to the market open.

Data Center Builder Legence Breaks Out. Up 80% Since September IPO.
26.01.2026

Data Center Builder Legence Breaks Out. Up 80% Since September IPO.

Legence, a major provider of heating and cooling systems to data centers, moved into another buy zone following its September IPO.

Legence Announces Full Exercise and Closing of Over-allotment Option
08.01.2026

Legence Announces Full Exercise and Closing of Over-allotment Option

SAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence”) today announced that the underwriters of the previously announced upsized secondary underwritten public offering (the “offering”) of 8,402,178 shares of its Class A common stock (“Common Stock”) by selling stockholders affiliated with Blackstone Inc. (the “Selling Stockholders”) have fully exercised their option to purchase an additional 1,260,326 shares of Common Stock at a price to the public of $45.00 per share. The exercise of the underwriters' option closed on January 8, 2026.

Видео

No Data

There is no data to display